36C25726Q0381.pdf

PDF 746 KB Posted

Attached to
6550--NEW - STX Core Lab QC Consumables
Solicitation number
36C25726Q0381
Issued by

About this file

This is a Standard Form 1449 Solicitation/Contract/Order for Commercial Products and Commercial Services issued by the Department of Veterans Affairs, Network Contracting Office 17, for the South Texas Veterans Health Care System.

The solicitation seeks FDA-approved brand-name quality control materials manufactured by Bio-Rad Laboratories compatible with Beckman Coulter AU 5800, DXI 800, and Tosoh HgbA1c analyzers, along with renewal support for the Unity Real Time Software program for quality control monitoring at the Core Laboratory of Pathology & Laboratory Medicine Service at Audie L. Murphy VA Hospital and Kerrville VA. The acquisition is structured as a single-award Indefinite Delivery, Indefinite Quantity (IDIQ) contract with a guaranteed minimum obligation of $13,000 and a maximum contract ceiling of $1,300,000 across five 12-month ordering periods from June 15, 2026, through June 14, 2031. The solicitation is on a Brand Name or Equal basis; offerors may propose Bio-Rad products or equivalent products meeting all salient characteristics. Proposals are due by May 8, 2026, at 10:00 AM Central Time, with a question cutoff date of May 4, 2026, at 10:00 AM Central Time. Questions should be submitted via email to Ognian Ivanov at ognian.ivanov@va.gov. Award is anticipated for June 15, 2026. The acquisition is unrestricted (not set aside for small business), and evaluation will be conducted on a Lowest Price Technically Acceptable (LPTA) basis considering technical acceptability, past performance, SDVOSB/VOSB participation, and price. Monthly invoicing in arrears is required through the VA's Tungsten Network electronic invoicing system at http://www.fsc.va.gov/einvoice.asp. The solicitation incorporates various FAR and VAAR clauses including provisions addressing security prohibitions, trade agreements, and Section 508 accessibility standards.

View the file

Other files

File Type Posted
36C25726Q0381 0001_1.docx DOCX document
36C25726Q0381 0001.pdf PDF
Attachment_2_Salient_Characteristics_36C25726Q0381.docx DOCX document
36C25726Q0381_Brand_Name_or_Equal_Justification-CO signed.pdf PDF
36C25726Q0381_1.docx DOCX document

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

PAGE 1 OF 1. REQUISITION NO.

2. CONTRACT NO. 3. AWARD/EFFECTIVE DATE 4. ORDER NO. 5. SOLICITATION NUMBER 6. SOLICITATION ISSUE DATE

a. NAME b. TELEPHONE NO. (No Collect Calls) 8. OFFER DUE DATE/LOCAL

TIME

9. ISSUED BY CODE 10. THIS ACQUISITION IS UNRESTRICTED OR SET ASIDE: % FOR:

SMALL BUSINESS

HUBZONE SMALL

BUSINESS

SERVICE-DISABLED

VETERAN-OWNED

SMALL BUSINESS

WOMEN-OWNED SMALL BUSINESS

(WOSB) ELIGIBLE UNDER THE WOMEN-OWNED

SMALL BUSINESS PROGRAM

EDWOSB

8(A)

NAICS:

SIZE STANDARD:

11. DELIVERY FOR FOB DESTINA-

TION UNLESS BLOCK IS

MARKED

SEE SCHEDULE

12. DISCOUNT TERMS

13a. THIS CONTRACT IS A

RATED ORDER UNDER

DPAS (15 CFR 700)

13b. RATING

14. METHOD OF SOLICITATION

RFQ IFB RFP

15. DELIVER TO CODE 16. ADMINISTERED BY CODE

17a. CONTRACTOR/OFFEROR CODE FACILITY CODE 18a. PAYMENT WILL BE MADE BY CODE

TELEPHONE NO. UEI: EFT:

PHONE: FAX:

17b. CHECK IF REMITTANCE IS DIFFERENT AND PUT SUCH ADDRESS IN OFFER

18b. SUBMIT INVOICES TO ADDRESS SHOWN IN BLOCK 18a UNLESS BLOCK BELOW IS CHECKED

SEE ADDENDUM

19. 20. 21. 22. 23. 24.

ITEM NO. SCHEDULE OF SUPPLIES/SERVICES QUANTITY UNIT UNIT PRICE AMOUNT

(Use Reverse and/or Attach Additional Sheets as Necessary)

25. ACCOUNTING AND APPROPRIATION DATA 26. TOTAL AWARD AMOUNT (For Govt. Use Only)

27a. SOLICITATION INCORPORATES BY REFERENCE FAR 52.212-1, 52.212-4. FAR 52.212-3 AND 52.212-5 ARE ATTACHED. ADDENDA ARE ARE NOT ATTACHED.

27b. CONTRACT/PURCHASE ORDER INCORPORATES BY REFERENCE FAR 52.212-4. FAR 52.212-5 IS ATTACHED. ADDENDA ARE ARE NOT ATTACHED

28. CONTRACTOR IS REQUIRED TO SIGN THIS DOCUMENT AND RETURN _______________ 29. AWARD OF CONTRACT: REF. ___________________________________ OFFER COPIES TO ISSUING OFFICE. CONTRACTOR AGREES TO FURNISH AND DATED ________________________________. YOUR OFFER ON SOLICITATION DELIVER ALL ITEMS SET FORTH OR OTHERWISE IDENTIFIED ABOVE AND ON ANY (BLOCK 5), INCLUDING ANY ADDITIONS OR CHANGES WHICH ARE ADDITIONAL SHEETS SUBJECT TO THE TERMS AND CONDITIONS SPECIFIED SET FORTH HEREIN IS ACCEPTED AS TO ITEMS:

30a. SIGNATURE OF OFFEROR/CONTRACTOR 31a. UNITED STATES OF AMERICA (SIGNATURE OF CONTRACTING OFFICER)

30b. NAME AND TITLE OF SIGNER (TYPE OR PRINT) 30c. DATE SIGNED 31b. NAME OF CONTRACTING OFFICER (TYPE OR PRINT) 31c. DATE SIGNED

AUTHORIZED FOR LOCAL REPRODUCTION (REV. NOV 2021)

PREVIOUS EDITION IS NOT USABLE Prescribed by GSA - FAR (48 CFR) 53.212

7. FOR SOLICITATION

INFORMATION CALL:

STANDARD FORM 1449

SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES

OFFEROR TO COMPLETE BLOCKS 12, 17, 23, 24, & 30

671-26-3-121-0781

36C25726Q0381 04-28-2026

Ognian D. Ivanov (210) 620-1571 05-08-2026

10:00 CDT

36C257 Department Of Veterans Affairs Network Contracting Office 17

5441 Babcock Road Ste. 302 San Antonio TX 78240

X

325413

1250 Employees

N/A

X

Department of Veterans Affairs South Texas Veterans Health Care System P&LMS Service 7400 Merton Minter St San Antonio TX 78229-4401

This is accomplished through the Tungsten Network located at:

http://www.fsc.va.gov/einvoice.asp This is mandatory and the sole method for submitting invoices.

(877) 353-9791 (512) 460-5540

See CONTINUATION Page

This solicitation is issued pursuant to the Federal Acquisition Regulation (FAR), Veterans Affairs Acquisition Regulation (VAAR), and applicable supplements. Offerors are responsible for reading, understanding, and complying with all terms, conditions, instructions, and requirements of of this solicitation.

Period of Performance Ordering Period 1 6/15/2026 - 6/14/2027 Ordering Period 2 6/15/2027 - 6/14/2028 Ordering Period 3 6/15/2028 - 6/14/2029 Ordering Period 4 6/15/2029 - 6/14/2030 Ordering Period 5 6/15/2030 - 6/14/2031

All questions concerning this solicitation shall be submitted in writing to the Contract Specialist by 05/04/2026 10 AM CT via email: ognian.ivanov@va.gov Responses will be posted as a SAM.gov amendment to the solicitation.

See CONTINUATION Page x one

Jose Campa Contracting Officer

VHASTXIvanoO Cross-Out

36C25726Q0381

Table of Contents

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 CONTRACT ADMINISTRATION DATA

B.2 STATEMENT OF WORK (SOW)

B.2 PRICE/COST SCHEDULE

ITEM INFORMATION

B.4 DELIVERY SCHEDULE

SECTION C - CONTRACT CLAUSES

C.1 52.252-2 CLAUSES INCORPORATED BY REFERENCE (FEB 1998)

C.2 52.216-18 ORDERING (AUG 2020)

C.3 52.216-19 ORDER LIMITATIONS (OCT 1995)

C.4 52.216-22 INDEFINITE QUANTITY (NOV 2025) (DEVIATION)

C.5 52.240-91 SECURITY PROHIBITIONS AND EXCLUSIONS (NOV 2025)

(DEVIATION)

C.6 52.252-6 AUTHORIZED DEVIATIONS IN CLAUSES (NOV 2020)

C.7 VAAR 852.201-70 CONTRACTING OFFICER'S REPRESENTATIVE (DEC 2022)

C.8 VAAR 852.203-70 COMMERCIAL ADVERTISING (MAY 2018)

C.9 VAAR 852.215-70 SERVICE-DISABLED VETERAN-OWNED AND VETERAN-

OWNED SMALL BUSINESS EVALUATION FACTORS (JAN 2023) (DEVIATION)

C.10 VAAR 852.215-71 EVALUATION FACTOR COMMITMENTS (OCT 2019)

C.11 VAAR 852.222-71 COMPLIANCE WITH EXECUTIVE ORDER 13899

(DEVIATION)(APR 2025)

C.12 VAAR 852.232-72 ELECTRONIC SUBMISSION OF PAYMENT REQUESTS

(NOV 2018)

C.13 VAAR 852.242-71 ADMINISTRATIVE CONTRACTING OFFICER (OCT 2020) . 65

C.14 VAAR 852.246-71 REJECTED GOODS (OCT 2018)

C.15 VAAR 852.247-73 PACKING FOR DOMESTIC SHIPMENT (OCT 2018)

SECTION D - CONTRACT DOCUMENTS, EXHIBITS, OR ATTACHMENTS

SECTION E - SOLICITATION PROVISIONS

E.1 52.252-1 SOLICITATION PROVISIONS INCORPORATED BY REFERENCE (FEB

1998)

E.2 52.209-7 INFORMATION REGARDING RESPONSIBILITY MATTERS (OCT 2018)

E.3 52.211-6 BRAND NAME OR EQUAL AUG 1999

E.4 ADDENDUM to FAR 52.212-1 INSTRUCTIONS TO OFFERORS—COMMERCIAL

PRODUCTS AND COMMERCIAL SERVICES

E.5 52.212-2 EVALUATION—COMMERCIAL PRODUCTS AND COMMERCIAL

SERVICES (NOV 2021)

E.6 52.225-6 TRADE AGREEMENTS CERTIFICATE (FEB 2021)

E.7 52.233-2 SERVICE OF PROTEST (SEP 2006)

E.8 52.240-90 SECURITY PROHIBITIONS AND EXCLUSIONS REPRESENTATIONS

AND CERTIFICATIONS (NOV 2025) (DEVIATION)

E.9 52.252-5 AUTHORIZED DEVIATIONS IN PROVISIONS (NOV 2020)

E.10 VAAR 852.215-72 NOTICE OF INTENT TO RE-SOLICIT (OCT 2019)

E.11 VAAR 852.233-70 PROTEST CONTENT/ALTERNATIVE DISPUTE

RESOLUTION (OCT 2018)

E.12 VAAR 852.233-71 ALTERNATE PROTEST PROCEDURE (OCT 2018)

E.13 VAAR 852.239-75 INFORMATION AND COMMUNICATION TECHNOLOGY

ACCESSIBILITY NOTICE (FEB 2023)

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 CONTRACT ADMINISTRATION DATA

1. Contract Administration: All contract administration matters will be handled by the following individuals:

a. CONTRACTOR:

b. GOVERNMENT: Contracting Officer 36C257 Jose Campa

Department Of Veterans Affairs

Network Contracting Office 17

5441 Babcock Road Ste. 302

San Antonio TX 78240

2. CONTRACTOR REMITTANCE ADDRESS: All payments by the Government to the contractor will be made in accordance with:

[X] 52.232-33, Payment by Electronic Funds Transfer—System For Award Management, or

[] 52.232-36, Payment by Third Party

3. INVOICES: Invoices shall be submitted in arrears:

a. Quarterly []

b. Semi-Annually []

c. Other [x] monthly, in arrears

4. GOVERNMENT INVOICE ADDRESS: All Invoices from the contractor shall be submitted electronically in accordance with VAAR Clause 852.232-72 Electronic Submission of Payment Requests.

http://www.fsc.va.gov/einvoice.asp

This is mandatory and the sole method for submitting invoices.

ACKNOWLEDGMENT OF AMENDMENTS: The offeror acknowledges receipt of amendments to the Solicitation numbered and dated as follows:

AMENDMENT NO DATE

B.2 STATEMENT OF WORK (SOW)

Scope

The STVHCS has a need for FDA approved brand name quality control materials compatible with the following instrumentation: Beckman Coulter AU 5800, DXI 800 and Tosoh HgbA1c and the Unity Real Time Software used to monitor Quality Control for compliance with CLIA standards for the Core Laboratory of Pathology & Laboratory Medicine Service at Audie L. Murphy VA Hospital and Kerrville VA. In addition, there is a need for renewal support of the Unity Real Time Software program that works in conjunction with the quality controls to detect systematic errors. Due to the required need for calibration, validation and other requirements of CLIA, the only controls that are validated for use are brand name quality control materials manufactured by Bio Rad Laboratories.

Technical Requirements:

• The vendor must be able to provide ready-to-use Quality Control materials that are compatible with the following instrumentation:

a. Beckman Coulter AU 5800

b. Beckman Coulter DXI 800

c. TOSOH HgbA1c

• The vendor shall be able to provide material to cover all analytes listed.

• The vendor shall be able to supply a local based, not web-based, expert quality control program which can utilize data as provided by the Beckman Coulter instruments via the Data Innovations Instrument Manager middleware.

• The Quality Control program shall be able to provide a report comparing the affiliated hospitals and clinics.

• The Quality Control Program shall provide interlaboratory peer group comparisons.

• The Quality Control program shall be able to download the monthly peer data directly to the local software database to compare lab values to peers on all the software's charts and graphs.

• The Quality Control program shall support the use of Multi Levey Jennings for QC result comparison between instruments.

• The vendor must be able to provide next day delivery to both Audie and Kerrville locations of as needed quality controls listed below.

• The vendor must provide confirmation of order same day as order request is received.

• The vendor must provide tracking information and provide an estimated delivery time.

• The vendor must be able to sequester quality control lots so that the lot numbers will be the same throughout the contract year.

• The Quality Controls must be FDA approved and meet all regulatory guidelines set for by the STVHCS and VHA Handbook 1106.1.

• The vendor must have an Emergency Contingency plan to meet the following criteria:

a. If the supplies are found to be defective and unsuitable for use with the Core Laboratory equipment, or the Contractor has failed to comply with the requirements for routine supply delivery, the Contractor is required to deliver the supplies within 24 hours of receipt of a verbal order for emergency delivery.

b. If either circumstance has occurred, the Contractor shall deliver to the Government site in the most expeditious manner possible without additional cost to the Government, the necessary consumables in sufficient quantity as required to allow operation of the Contractor’s Core Laboratory equipment for one week (under normal Government test load volume).

c. If additional requests for emergency supply delivery are required by the Government, they shall be honored by the Contractor until the arrival at the laboratory of the monthly standing order/routine supplies delivery.

d. The vendor must provide confirmation of order same day as order request is received.

e. The vendor must provide tracking information and provide an estimated delivery time.

• The Vendor agrees to supply the customer with the following control material. All material must meet or exceed the following specifications:

1. Multiqual Level 1(Product No. 697) or equivalent: Human serum based, liquid, ready to use. Shall have 30-day unopened stability at 2-8C. Shall have 14-day open vial stability at 2-8C. Shall have low osmolality value in level 1. Package of 12 x 10 mL. Shall have the following analytes:

Acid Phosphatase, Calcium (Total), Glucose, Potassium, Albumin, Carbon Dioxide ,TIBC, Protein (Total), Alkaline Phosphatase, Chloride, UIBC, Sodium, ALT, Cholesterol (HDL), LDH, Triglycerides, Amylase, Cholesterol (LDL), Lactic Acid, Urea Nitrogen, Amylase (Pancreatic), Cholesterol (Total), Lipase, Uric Acid, AST, Cholinesterase, Magnesium, Iron, Bilirubin (Direct), Creatinine, Osmolality, Bilirubin (Neonatal), CK, Phosphorus, Bilirubin (Total), GGT

2. Multiqual Level 2(Product No. 698) or equivalent: Human serum based, liquid, ready to use. Shall have 30-day unopened stability at 2-8C. Shall have 14-day

Acid Phosphatase, Calcium (Total), Glucose, Potassium, Albumin, Carbon Dioxide ,TIBC, Protein (Total), Alkaline Phosphatase, Chloride, UIBC, Sodium, ALT, Cholesterol (HDL), LDH, Triglycerides, Amylase, Cholesterol (LDL), Lactic Acid, Urea Nitrogen, Amylase (Pancreatic), Cholesterol (Total), Lipase, Uric Acid, AST, Cholinesterase, Magnesium, Iron, Bilirubin (Direct), Creatinine, Osmolality, Bilirubin (Neonatal), CK, Phosphorus, Bilirubin (Total), GGT

3. Multiqual Level 3 (Product No. 699) or equivalent: Human serum based, liquid, ready to use. Shall have 30-day unopened stability at 2-8C. Shall have 14-day

Acid Phosphatase, Calcium (Total), Glucose, Potassium, Albumin, Carbon Dioxide ,TIBC, Protein (Total), Alkaline Phosphatase, Chloride, UIBC, Sodium, ALT, Cholesterol (HDL), LDH, Triglycerides, Amylase, Cholesterol (LDL), Lactic Acid, Urea Nitrogen, Amylase (Pancreatic), Cholesterol (Total), Lipase, Uric Acid, AST, Cholinesterase, Magnesium, Iron, Bilirubin (Direct), Creatinine, Osmolality, Bilirubin (Neonatal), CK, Phosphorus, Bilirubin (Total), GGT

4. Liquichek Immunoassay Plus Level 1(Product No. 361) or equivalent: Human serum based, liquid, ready to use. Shall have 14-day open vial stability at 2-8C except Folate which shall have 7-day stability. Package of 12 x 5 mL. Shall have the following analytes:

Acetaminophen, hCG-Beta, Phenytoin, Testosterone, AFP, Imipramine, Phenytoin (Free), Theophylline, Amikacin, IgA, Procainamide, Tobramycin, Amitriptyline, IgE, Progesterone, TSH, Caffeine, IgG, Prolactin, Valproic Acid, Carbamazepine, IgM, PSA, Vancomycin, CEA, Iron, PSA (Free), Vitamin B12, Cortisol, LH, Salicylate, Desipramine, Lidocaine, SHBG, Digoxin, Lithium, T3 (Free), Ferritin, NAPA , T3 (Total), Folate, Nortriptyline, T4 (Free), FSH, Phenobarbital, T4 (Total), Gentamicin

5. Liquichek Immunoassay Plus Level 2(Product No. 362) or equivalent: Human serum based, liquid, ready to use. Shall have 14-day open vial stability at 2-8C except Folate which shall have 7-day stability. Package of 12 x 5 mL. Shall have the following analytes:

Acetaminophen, hCG-Beta, Phenytoin, Testosterone, AFP, Imipramine, Phenytoin (Free), Theophylline, Amikacin, IgA, Procainamide, Tobramycin, Amitriptyline, IgE, Progesterone, TSH, Caffeine, IgG, Prolactin, Valproic Acid, Carbamazepine, IgM, PSA, Vancomycin, CEA, Iron, PSA (Free), Vitamin B12, Cortisol, LH, Salicylate, Desipramine, Lidocaine, SHBG, Digoxin, Lithium, T3 (Free), Ferritin, NAPA, T3 (Total), Folate, Nortriptyline, T4 (Free), FSH, Phenobarbital, T4 (Total), Gentamicin

6. Liquichek Immunoassay Plus Level 3(Product No. 363) or equivalent: Human serum based, liquid, ready to use. Shall have 14-day open vial stability at 2-8C except Folate which shall have 7-day stability. Package of 12 x 5 mL. Shall have the following analytes:

Acetaminophen, hCG-Beta, Phenytoin, Testosterone, AFP, Imipramine, Phenytoin (Free), Theophylline, Amikacin, IgA, Procainamide, Tobramycin, Amitriptyline, IgE, Progesterone, TSH, Caffeine, IgG, Prolactin, Valproic Acid, Carbamazepine, IgM, PSA, Vancomycin, CEA, Iron, PSA (Free), Vitamin B12, Cortisol, LH, Salicylate, Desipramine, Lidocaine, SHBG, Digoxin, Lithium, T3 (Free), Ferritin, NAPA, T3 (Total), Folate, Nortriptyline, T4 (Free), FSH, Phenobarbital, T4 (Total), Gentamicin

7. Liquichek Ethanol/Ammonia Control Level 1(Product No. 544) or equivalent:

Shall be liquid, ready to use. Ammonia concentration in level 1 must be within the normal reference range. Shall have at least a 2 year shelf life and 20 day open vial stability at 2-8C . Package of 6 x 3 mL. Shall have the following analytes:

Ammonia, Ethanol

8. Liquichek Ethanol/Ammonia Control Level 2(Product No. 545) or equivalent:

normal reference range. Shall have at least a 2 year shelf life and 20 day open vial

9. Liquichek Ethanol/Ammonia Control Level 3(Product No. 546) or equivalent:

normal reference range. Shall have at least a 2 year shelf life and 20 day open vial

10. Liquichek Cardiac Marker Plus Control LT Level 1(Product No. 146) or equivalent: Shall be liquid, human serum based, ready to use. Shall have 20 day open vial stability at 2-8C for most analytes . Package of 6 x 3 mL. Shall have the following analytes:

CK (Total), Digitoxin, NT-proBNP, CKMB, Homocysteine, Troponin, CRP, Myoglobin, Troponin T

11. Liquichek Cardiac Marker Plus Control LT Level 2(Product No. 147) or equivalent: Shall be liquid, human serum based, ready to use. Shall have 20 day

12. Liquichek Cardiac Marker Plus Control LT Level 3(Product No. 148) or equivalent: Shall be liquid, human serum based, ready to use. Shall have 20 day

13. Liquichek Diabetes Control Level 1(Product No. 12011343) or equivalent: Shall be liquid, human whole blood based, ready to use. Shall have 6 month shelf life and 14 day open vial stability at 2-8C. Package of 6 x 1 mL. Shall have the following analytes:

Hemoglobin A1C, Hemoglobin (Total)

14. Liquichek Diabetes Control Level 2(Product No. 12011344) or equivalent: Shall be liquid, human whole blood based, ready to use. Shall have 6 month shelf life and 14 day open vial stability at 2-8C. Package of 6 x 1 mL. Shall have the following

15. Liquichek Diabetes Control Level 3(Product No. 12011345) or equivalent: Shall be liquid, human whole blood based, ready to use. Shall have 6 month shelf life and 14 day open vial stability at 2-8C. Package of 6 x 1 mL. Shall have the following

16. Liquichek Urine Chemistry Control Level 1(Product No. 397) or equivalent:

Shall be human urine based, liquid, ready to use. Shall have at least 30 day open vial stability at 2-8C. Package of 12 x 10 mL. Shall contain the following analytes:

Amylase, Microalbumin, Sodium, Calcium, Osmolality, Specific Gravity, Chloride, pH, Urea, Cortisol, Phosphorus, Urea Nitrogen, Creatinine, Potassium, Uric Acid, Glucose, Pregnancy (Qualitative), Magnesium, Protein (Total)

17. Liquichek Urine Chemistry Control Level 2(Product No. 398) or equivalent:

Shall be human urine based, liquid, ready to use. Shall have at least 30 day open vial stability at 2-8C. Package of 12 x 10 mL. Shall contain the following analytes:

Amylase, Microalbumin, Sodium, Calcium, Osmolality, Specific Gravity, Chloride, pH, Urea, Cortisol, Phosphorus, Urea Nitrogen, Creatinine, Potassium, Uric Acid, Glucose, Pregnancy (Qualitative), Magnesium, Protein (Total)

18. Liquichek Immunology Control Level 1(Product No. 594) or equivalent: Shall be human serum based, liquid and ready to use. Shall have at least 30 day open vial stability at 2-8C. Package of 6 x 3 mL. Shall contain the following analytes:

Albumin, Complement C3, IgM, Alpha-1-Antitrypsin, Complement C4, Kappa Light Chain, Antistreptolysin O, CRP, Lambda Light Chain, Antithrombin III, Haptoglobin, Prealbumin, Apolipoprotein A-1, IgA, Protein (Total), Apolipoprotein B, IgE, Rheumatoid Factor, Ceruloplasmin, IgG, Transferrin

19. Liquichek Immunology Control Level 2(Product No. 595) or equivalent: Shall be human serum based, liquid and ready to use. Shall have at least 30 day open vial stability at 2-8C. Package of 6 x 3 mL. Shall contain the following analytes:

Albumin, Complement C3, IgM, Alpha-1-Antitrypsin, Complement C4, Kappa Light Chain, Antistreptolysin O, CRP, Lambda Light Chain, Antithrombin III, Haptoglobin, Prealbumin, Apolipoprotein A-1, IgA, Protein (Total), Apolipoprotein B, IgE, Rheumatoid Factor, Ceruloplasmin, IgG, Transferrin

20. Liquichek Immunology Control Level 3(Product No. 596) or equivalent: Shall be human serum based, liquid and ready to use. Shall have at least 30 day open vial stability at 2-8C. Package of 6 x 3 mL. Shall contain the following analytes:

Albumin, Complement C3, IgM, Alpha-1-Antitrypsin, Complement C4, Kappa Light Chain, Antistreptolysin O, CRP, Lambda Light Chain, Antithrombin III, Haptoglobin, Prealbumin, Apolipoprotein A-1, IgA, Protein (Total), Apolipoprotein B, IgE, Rheumatoid Factor, Ceruloplasmin, IgG, Transferrin

21. Liquichek Spinal Fluid Control Level 1(Product No. 751) or equivalent: Shall be human based, liquid and ready to use. Shall have at least 30 day open vial stability at 2-8C. Package of 6 x 3 mL. Shall contain the following analytes:

Albumin, IgG, Protein electrophoresis, Chloride, IgM, Protein (Total), Glucose, Lactate, Sodium, IgA, LDH

22. Liquichek Spinal Fluid Control Level 2(Product No. 752) or equivalent: Shall be human based, liquid and ready to use. Shall have at least 30 day open vial stability at 2-8C. Package of 6 x 3 mL. Shall contain the following analytes:

Albumin, IgG, Protein electrophoresis, Chloride, IgM, Protein (Total), Glucose, Lactate, Sodium, IgA, LDH

23. Liquichek Urine Toxicology Screen Control Level S1E Low Opiate (Product No.

423) or equivalent: Shall be human urine based. Shall have at least 3 year shelf life at 2-8C. Package 10 x 10 mL. Shall contain the following analytes:

d-Metamphetamines, Barbiturates, Benzodiazepines, Cannabinoids, Cocaine, Opiates, Lormetazepam, TCAs, Benzoylecgonine, Morphine, Nortriptyline, Ethanol, Phencyclidine (PCP), LSD, Propoxyphene, Methadone, Methaqualone

24. Liquichek Urine Toxicology Screen Control Level S2E Low Opiate (Product No.

424) or equivalent: Shall be human urine based. Shall have at least 3 year shelf life at 2-8C. Package 10 x 10 mL. Shall contain the following analytes:

d-Metamphetamines, Barbiturates, Benzodiazepines, Cannabinoids, Cocaine, Opiates, Lormetazepam, TCAs, Benzoylecgonine, Morphine, Nortriptyline, Ethanol, Phencyclidine (PCP), LSD, Propoxyphene, Methadone, Methaqualone

25. Liquichek Cardiac Markers Plus Control LT, Level 1B (Product No. 27105) or equivalent: Shall be liquid, human serum based, 6 x 3 mL. Shall contain the

Troponin I, Troponin T, BNP, NT-proBNP, CK, CK-MB, CRP, and Myoglobin

26. Liquichek Specialty Immunoassay Plus Control, Level 1 (Product No.

12015645) or equivalent: Shall be assayed, liquid human serum based, 6 x 5 mL.

Shall contain the following analytes:

Procalcitonin (PCT), Active Vitamin B12, IL-6, PTH (Intact), 25-OH Vitamin D, Anti- Tg, Anti-TPO, C-Peptide

27. Liquichek Specialty Immunoassay Plus Control, Level 2 (Product No.

12015646) or equivalent: Shall be assayed, liquid human serum based, 6 x 5 mL.

Shall contain the following analytes:

Procalcitonin (PCT), Active Vitamin B12, IL-6, PTH (Intact), 25-OH Vitamin D, Anti- Tg, Anti-TPO, C-Peptide

28. Liquichek Specialty Immunoassay Plus Control, Level 3 (Product No.

12015647) or equivalent: Shall be assayed, liquid human serum based, 6 x 5 mL.

Shall contain the following analytes:

Procalcitonin (PCT), Active Vitamin B12, IL-6, PTH (Intact), 25-OH Vitamin D, Anti- Tg, Anti-TPO, C-Peptide

29. Unity Real Time – 1 Year Subscription (Product No. 804-1)

30. DirectConnect – 1 Year Support (Product No. 857-1)

31. Unity Real Time 5 ADD User – 1 Year (Product No. 804-U1)

32. Unity Alert 1 Year Subscription (Product No. 806-1)

The Contractor is required to provide a continuously stocked inventory of quality controls to ensure the Core Laboratory can properly perform Quality control daily as required. These items shall be of the highest quality, to ensure precision and accuracy.

Expiration date must be clearly marked on all supplies. Alert/Notification of any delays in shipment as well as any or all technical advisory/recalls/alerts, prior to or simultaneously with field alerts should be forwarded to the designated individuals determined at contract award.

Special handling for emergency orders of supplies: If the supplies are found to be defective and unsuitable for use with the Core Laboratory equipment, or the Contractor has failed to comply with the requirements for routine supply delivery, the Contractor is required to deliver the supplies within 24 hours of receipt of a verbal order for emergency delivery. If either circumstance has occurred, the Contractor shall deliver to the Government site in the most expeditious manner possible without additional cost to the Government, the necessary consumables in sufficient quantity as required to allow operation of the Contractor’s Core Laboratory equipment for one week (under normal Government test load volume). If additional requests for emergency supply delivery are required by the Government, they shall be honored by the Contractor until the arrival at the laboratory of the monthly standing order/routine supplies delivery.

Location

The quality controls and renewal support of the Unity Real Time software will be used in the Core laboratory located in the Pathology and Laboratory Medicine Service’s San Antonio Laboratories of the STVHCS and Kerrville VA.

Deliverables/Supplies

Quality control reagents and software for Quality Control Assurance in the Core Laboratory.

Government Inherent Functions:

Contractor shall not perform inherently governmental functions. This includes, but is not limited to: determination of agency policy, determination of Federal program priorities for budget requests, direction and control of government employees, selection or non-selection of individuals for Federal Government employment including the interviewing of individuals for employment, approval of position descriptions and performance standards for Federal employees, approving any contractual documents, approval of Federal licensing actions and inspections, and/or determination of budget policy, guidance, and strategy.

General Duties, Requirements, and Expectations:

1. Be professionally competent to handle required duties.

2. Work with staff to ensure safety measures are in place and documented.

3. Services provided under the terms of this contract are required to be in compliance with the American Association of Blood Banks (AABB) and College of American Pathologists (CAP) accreditation policies and all applicable Federal, State and Government laws required by the Veteran’s Healthcare System and VHA Handbook 1106.1.

Information Systems Officer, Information Protection:

The contractor will not have access to VA Desktop computers, nor will they have access to online resources belonging to the government while conducting services. If removal of equipment from the VA is required, any memory storage devices, such as hard drives, solid state drives and non-volatile memory units will remain in VA control and will not be removed from VA custody.

Privacy Officer:

The contractor will not have access to protected Patient Health Information (PHI) nor will they have the capability of accessing patient information during the services provided to the VA and if removal of equipment from the VA is required, any memory storage devices, such as hard drives, solid state drives and non-volatile memory units will remain in VA control and will not be removed from VA custody. All research data available for Contractor analyses is de-identified.

Records Manager:

There will be no federal records created, maintained, used or dispositioned with this contract; regardless of format [paper, electronic, etc.] or mode of transmission [e-mail, fax, etc.].

See attached document: Attachment_2_Salient_Characteristics_36C25726Q0381.

(End of SOW)

B.2 PRICE/COST SCHEDULE

The Government intends to award a single-award Indefinite Delivery, Indefinite Quantity (IDIQ) contract, under which Firm-Fixed-Price delivery orders will be issued.

(a) Guaranteed Minimum. The Government guarantees a minimum obligation under this contract of $13, 000.00. This minimum shall be satisfied through issuance of an initial Firm- Fixed-Price delivery order concurrent with contract award. Upon issuance of the initial delivery order, the Government’s minimum obligation under FAR 52.216-22 is satisfied.

(b) Maximum Ceiling. The maximum dollar value of all delivery orders issued under this contract, inclusive of the base ordering period and all four (4) option ordering periods, shall not exceed $1, 300, 000. 00.

(c) No Obligation Beyond Minimum. Except for the guaranteed minimum stated in paragraph (a) above, the Government is under obligation to place any additional orders under this contract.

Ordering Period 1 June 15,2026 through June 14,2027

Ordering Period 2 June 15,2027 through June 14,2028

Ordering Period 3 June 15,2028 through June 14,2029

Ordering Period 4 June 15,2029 through June 14,2030

Ordering Period 5 June 15,2030 through June 14,2031

ITEM INFORMATION

ITEM

NUMBER

DESCRIPTION OF

SUPPLIES/SERVICES QUANTITY UNIT UNIT PRICE AMOUNT

44.00 EA __________________ __________________

CATALOG NO. 146 DESCRIPTION: CARD MKR LT PLUS 1 LIQ

6X3ML

Ordering Period 1 POP Begin: 06-15-2026 POP End: 06-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

CATALOG NO. 147 DESCRIPTION: CARD MKR LT PLUS 2 LIQ

6X3ML

Ordering Period 1 POP Begin: 06-15-2026 POP End: 06-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LOCAL STOCK NUMBER: 147

CATALOG NO. 148 DESCRIPTION: CARD MKR LT PLUS 3 LIQ

6X3ML

Ordering Period 1 POP Begin: 06-15-2026 POP End: 06-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LOCAL STOCK NUMBER: 148

64.00 EA __________________ __________________

CATALOG NO. 361 DESCRIPTION: IA PLUS LIQ 1 12X5 ML

Ordering Period 1 POP Begin: 06-15-2026 POP End: 06-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LOCAL STOCK NUMBER: 361

CATALOG NO. 362 DESCRIPTION: IA PLUS LIQ 2 12X5 ML

Ordering Period 1 POP Begin: 06-15-2026 POP End: 06-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

LOCAL STOCK NUMBER: 362

CATALOG NO. 363 DESCRIPTION: IA PLUS LIQ 3 12X5 ML

Ordering Period 1 POP Begin: 06-15-2026 POP End: 06-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LOCAL STOCK NUMBER: 363

18.00 EA __________________ __________________

CATALOG NO. 397 DESCRIPTION: URINE CHEMISTRY 1 LIQ

12X10 ML

Ordering Period 1 POP Begin: 06-15-2026 POP End: 06-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LOCAL STOCK NUMBER: 397

CATALOG NO. 398 DESCRIPTION: URINE CHEMISTRY 2 LIQ

12X10 ML

Ordering Period 1 POP Begin: 06-15-2026 POP End: 06-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LOCAL STOCK NUMBER: 398

46.00 EA __________________ __________________

CATALOG NO. 544 DESCRIPTION: ETHANOL/AMMOINIA 1 LIQ

6X3 ML

Ordering Period 1 POP Begin: 06-15-2026 POP End: 06-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LOCAL STOCK NUMBER: 544

CATALOG NO. 545 DESCRIPTION: ETHANOL/AMMOINIA 2 LIQ

6X3 ML

Contract Period: Base

POP Begin: 06-15-2026 POP End: 06-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LOCAL STOCK NUMBER: 545

CATALOG NO. 546 DESCRIPTION: ETHANOL/AMMOINIA 3 LIQ

6X3 ML

Ordering Period 1 POP Begin: 06-15-2026 POP End: 06-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LOCAL STOCK NUMBER: 546

40.00 EA __________________ __________________

CATALOG NO. 594 DESCRIPTION: IMMUNOLOGY 1 LIQ 6X3 ML

Ordering Period 1 POP Begin: 06-15-2026 POP End: 06-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LOCAL STOCK NUMBER: 594

CATALOG NO. 595 DESCRIPTION: IMMUNOLOGY 2 LIQ 6X3 ML

Ordering Period 1 POP Begin: 06-15-2026 POP End: 06-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LOCAL STOCK NUMBER: 595

CATALOG NO. 596 DESCRIPTION: IMMUNOLOGY 3 LIQ 6X3 ML

Ordering Period 1 POP Begin: 06-15-2026 POP End: 06-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LOCAL STOCK NUMBER: 596

72.00 EA __________________ __________________

CATALOG NO. 697 DESCRIPTION: MULTIQUAL UNASSAY 1 LIQ

12X10 ML

Ordering Period 1 POP Begin: 06-15-2026 POP End: 06-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LOCAL STOCK NUMBER: 697

CATALOG NO. 698 DESCRIPTION: MULTIQUAL UNASSAY 2 LIQ

12X10 ML

Ordering Period 1 POP Begin: 06-15-2026 POP End: 06-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LOCAL STOCK NUMBER: 698

CATALOG NO. 699 DESCRIPTION: MULTIQUAL UNASSAY 3 LIQ

12X10 ML

Ordering Period 1 POP Begin: 06-15-2026 POP End: 06-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LOCAL STOCK NUMBER: 699

33.00 EA __________________ __________________

CATALOG NO. 751 DESCRIPTION: SPINAL FLUID 1 LIQ 6X3 ML

Ordering Period 1 POP Begin: 06-15-2026 POP End: 06-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LOCAL STOCK NUMBER: 751

CATALOG NO. 752 DESCRIPTION: SPINAL FLUID 2 LIQ 6X3 ML

Ordering Period 1 POP Begin: 06-15-2026 POP End: 06-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance

Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LOCAL STOCK NUMBER: 752

1.00 EA __________________ __________________

CATALOG NO. 804-1 DESCRIPTION: UNITY REAL TIME - 1 YEAR

SUBSCR

Ordering Period 1 POP Begin: 06-15-2026 POP End: 06-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LOCAL STOCK NUMBER: 804-1

CATALOG NO. 857-1 DESCRIPTION: DIRECTCONNECT 1 YEAR

ANNUAL

Ordering Period 1 POP Begin: 06-15-2026 POP End: 06-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LOCAL STOCK NUMBER: 857-1

CATALOG NO. 804-U1 DESCRIPTION: UNITY REAL TIME 5ADD

USER 1YR

Ordering Period 1 POP Begin: 06-15-2026 POP End: 06-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LOCAL STOCK NUMBER: 804-U1

CATALOG NO. 806-1 DESCRIPTION: UNITY ALERT 1 YEAR

ANNUAL

Ordering Period 1 POP Begin: 06-15-2026 POP End: 06-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LOCAL STOCK NUMBER: 806-1

11.00 EA __________________ __________________

CATALOG NO. 423 DESCRIPTION: U TOX S1E LOW OP LIQ

10X10 ML

Ordering Period 1 POP Begin: 06-15-2026 POP End: 06-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LOCAL STOCK NUMBER: 423

CATALOG NO. 424 DESCRIPTION: U TOX S2E LOW OP LIQ

10X10 ML

Ordering Period 1 POP Begin: 06-15-2026 POP End: 06-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LOCAL STOCK NUMBER: 424

CATALOG NO. 12011343 DESCRIPTION: DIABETES 1 LIQ 6X1 ML

Ordering Period 1 POP Begin: 06-15-2026 POP End: 06-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LOCAL STOCK NUMBER: 12011343

CATALOG NO. 12011344 DESCRIPTION: DIABETES 2 LIQ 6X1 ML

Ordering Period 1 POP Begin: 06-15-2026 POP End: 06-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LOCAL STOCK NUMBER: 12011344

CATALOG NO. 12011345 DESCRIPTION: DIABETES 3 LIQ 6X1 ML

Ordering Period 1 POP Begin: 06-15-2026 POP End: 06-14-2027

Manufacturing

PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LOCAL STOCK NUMBER: 12011345

CATALOG NO. 27105 DESCRIPTION: CARD MKR LT PLUS 1B LIQ

6X3 ML

Ordering Period 1 POP Begin: 06-15-2026 POP End: 06-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LOCAL STOCK NUMBER: 27105

31.00 EA __________________ __________________

CATALOG NO. 12015645 DESCRIPTION: SPECIALTY IA PLUS

LEVEL 1 6X5 ML

Ordering Period 1 POP Begin: 06-15-2026 POP End: 06-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LOCAL STOCK NUMBER: 12015645

CATALOG NO. 12015646 DESCRIPTION: SPECIALTY IA PLUS

LEVEL 2 6X5 ML

Ordering Period 1 POP Begin: 06-15-2026 POP End: 06-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LOCAL STOCK NUMBER: 12015646

CATALOG NO. 12015647 DESCRIPTION: SPECIALTY IA PLUS

LEVEL 3 6X5 ML

Ordering Period 1 POP Begin: 06-15-2026 POP End: 06-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LOCAL STOCK NUMBER: 12015647

CATALOG NO. 146 DESCRIPTION: CARD MKR LT PLUS 1 LIQ

6X3ML

Ordering Period 2 POP Begin: 06-15-2027 POP End: 06-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

6X3ML

Ordering Period 2 POP Begin: 06-15-2027 POP End: 06-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, 6X3ML

Ordering Period 2 POP Begin: 06-15-2027 POP End: 06-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Ordering Period 2 POP Begin: 06-15-2027 POP End: 06-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Ordering Period 2 POP Begin: 06-15-2027 POP End: 06-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance

Ordering Period 2 POP Begin: 06-15-2027 POP End: 06-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, 12X10 ML

Ordering Period 2 POP Begin: 06-15-2027 POP End: 06-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, 12X10 ML

Ordering Period 2 POP Begin: 06-15-2027 POP End: 06-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, 6X3 ML

Ordering Period 2 POP Begin: 06-15-2027 POP End: 06-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, 6X3 ML

Ordering Period 2 POP Begin: 06-15-2027 POP End: 06-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, 6X3 ML

Ordering Period 2 POP Begin: 06-15-2027 POP End: 06-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Ordering Period 2 POP Begin: 06-15-2027 POP End: 06-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Ordering Period 2 POP Begin: 06-15-2027 POP End: 06-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Ordering Period 2 POP Begin: 06-15-2027 POP End: 06-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

12X10 ML

Ordering Period 2 POP Begin: 06-15-2027 POP End: 06-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, 12X10 ML

Ordering Period 2 POP Begin: 06-15-2027 POP End: 06-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, 12X10 ML

Ordering Period 2 POP Begin: 06-15-2027 POP End: 06-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Ordering Period 2 POP Begin: 06-15-2027 POP End: 06-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Ordering Period 2 POP Begin: 06-15-2027

POP End: 06-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, SUBSCR

Ordering Period 2 POP Begin: 06-15-2027 POP End: 06-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, ANNUAL

Ordering Period 2 POP Begin: 06-15-2027 POP End: 06-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, USER 1YR

Ordering Period 2 POP Begin: 06-15-2027 POP End: 06-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, ANNUAL

Ordering Period 2 POP Begin: 06-15-2027 POP End: 06-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

10X10 ML

Ordering Period 2 POP Begin: 06-15-2027 POP End: 06-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, 10X10 ML

Ordering Period 2 POP Begin: 06-15-2027 POP End: 06-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Ordering Period 2 POP Begin: 06-15-2027 POP End: 06-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Ordering Period 2 POP Begin: 06-15-2027 POP End: 06-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Ordering Period 2 POP Begin: 06-15-2027 POP End: 06-14-2028

PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, 6X3 ML

Ordering Period 2 POP Begin: 06-15-2027 POP End: 06-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LEVEL 1 6X5 ML

Ordering Period 2 POP Begin: 06-15-2027 POP End: 06-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LEVEL 2 6X5 ML

Ordering Period 2 POP Begin: 06-15-2027 POP End: 06-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LEVEL 3 6X5 ML

Ordering Period 2 POP Begin: 06-15-2027 POP End: 06-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

6X3ML

Ordering Period 3 POP Begin: 06-15-2028 POP End: 06-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

6X3ML

Ordering Period 3 POP Begin: 06-15-2028 POP End: 06-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, 6X3ML

Ordering Period 3 POP Begin: 06-15-2028 POP End: 06-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Ordering Period 3 POP Begin: 06-15-2028 POP End: 06-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Ordering Period 3 POP Begin: 06-15-2028 POP End: 06-14-2029

PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Ordering Period 3 POP Begin: 06-15-2028 POP End: 06-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, 12X10 ML

Ordering Period 3 POP Begin: 06-15-2028 POP End: 06-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, 12X10 ML

Ordering Period 3 POP Begin: 06-15-2028 POP End: 06-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, 6X3 ML

Ordering Period 3 POP Begin: 06-15-2028 POP End: 06-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, 6X3 ML

Ordering Period 3 POP Begin: 06-15-2028 POP End: 06-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, 6X3 ML

Ordering Period 3 POP Begin: 06-15-2028 POP End: 06-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Ordering Period 3 POP Begin: 06-15-2028 POP End: 06-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Ordering Period 3 POP Begin: 06-15-2028 POP End: 06-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Ordering Period 3 POP Begin: 06-15-2028 POP End: 06-14-2029

PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, 12X10 ML

Ordering Period 3 POP Begin: 06-15-2028 POP End: 06-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, 12X10 ML

Ordering Period 3 POP Begin: 06-15-2028 POP End: 06-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, 12X10 ML

Ordering Period 3 POP Begin: 06-15-2028 POP End: 06-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Ordering Period 3 POP Begin: 06-15-2028 POP End: 06-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, CATALOG NO. 752 DESCRIPTION: SPINAL FLUID 2 LIQ 6X3 ML

Ordering Period 3 POP Begin: 06-15-2028 POP End: 06-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, SUBSCR

Ordering Period 3 POP Begin: 06-15-2028 POP End: 06-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, ANNUAL

Ordering Period 3 POP Begin: 06-15-2028 POP End: 06-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, USER 1YR

Ordering Period 3 POP Begin: 06-15-2028 POP End: 06-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, ANNUAL

Ordering Period 3 POP Begin: 06-15-2028

Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, 10X10 ML

Ordering Period 3 POP Begin: 06-15-2028 POP End: 06-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, 10X10 ML

Ordering Period 3 POP Begin: 06-15-2028 POP End: 06-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Ordering Period 3 POP Begin: 06-15-2028 POP End: 06-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Ordering Period 3 POP Begin: 06-15-2028 POP End: 06-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, CATALOG NO. 12011345 DESCRIPTION: DIABETES 3 LIQ 6X1 ML

Ordering Period 3 POP Begin: 06-15-2028 POP End: 06-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, 6X3 ML

Ordering Period 3 POP Begin: 06-15-2028 POP End: 06-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LEVEL 1 6X5 ML

Ordering Period 3 POP Begin: 06-15-2028 POP End: 06-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LEVEL 2 6X5 ML

Ordering Period 3 POP Begin: 06-15-2028 POP End: 06-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, LEVEL 3 6X5 ML

Ordering Period 3 POP Begin: 06-15-2028

Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, 6X3ML

Ordering Period 4 POP Begin: 06-15-2029 POP End: 06-14-2030 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

6X3ML

Ordering Period 4 POP Begin: 06-15-2029 POP End: 06-14-2030 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, 6X3ML

Ordering Period 4 POP Begin: 06-15-2029…

This is the start of the file's text. The full file is on GovTribe.

File details come from the government source that posted it. Updated .